These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 18191076)
1. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. Piconi L; Corgnali M; Da Ros R; Assaloni R; Piliego T; Ceriello A J Diabetes Complications; 2008; 22(1):38-45. PubMed ID: 18191076 [TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability. Schäfer A; Fraccarollo D; Eigenthaler M; Tas P; Firnschild A; Frantz S; Ertl G; Bauersachs J Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1071-7. PubMed ID: 15761193 [TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells. Huang B; Wu CH; Li FA; Liang SS; Shieh YH; Wang LD Kaohsiung J Med Sci; 2013 Jul; 29(7):347-52. PubMed ID: 23768697 [TBL] [Abstract][Full Text] [Related]
14. Propofol reduces apoptosis and up-regulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells. Wang B; Luo T; Chen D; Ansley DM Anesth Analg; 2007 Oct; 105(4):1027-33, table of contents. PubMed ID: 17898383 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation. Solini A; Rossi C; Santini E; Madec S; Salvati A; Ferrannini E J Hypertens; 2011 Oct; 29(10):1930-9. PubMed ID: 21881526 [TBL] [Abstract][Full Text] [Related]
16. In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin. Ajith TA; Riji T; Anu V Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):625-9. PubMed ID: 18177480 [TBL] [Abstract][Full Text] [Related]
17. Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus. Schäfer A; Fraccarollo D; Vogt C; Flierl U; Hemberger M; Tas P; Ertl G; Bauersachs J Biochem Pharmacol; 2007 May; 73(9):1367-75. PubMed ID: 17270148 [TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice. Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361 [TBL] [Abstract][Full Text] [Related]